Fas Antigen/APO-1 (CD95) Expression on Myeloma Cells
- 1 January 1996
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 23 (5-6) , 521-531
- https://doi.org/10.3109/10428199609054860
Abstract
Many factors involved in the proliferation of myelomas have been reported, and the relationship between these factors and the pathogenesis of multiple myeloma has been discussed. We found that most myeloma cells express Fas antigen/APO-1 (CD95), a cell surface antigen that mediates apoptosis. However only some cells are sensitive to anti-Fas antibody and undergo apoptosis. These data indicate that some multiple myelomas are generated not only by cell proliferation but also by cell immortalization. The mechanism by which myelomas are immortalized is still unclear, but Bcl-2, Bcl-xL, adult T cell leukemia derived factor (ADF), soluble Fas are all candidate factors for this mechanism. The possibility also exists that inducers of apoptosis, e.g. tumor necrosis factor(TNF), interleukin-lβ-converting enzyme(lCE), Bcl-xS, or Bax, do not have a lethal effect. In this review, we focus on the system that immortalizes myeloma cells, and suggest the possibility that multiple myeloma constitutes one group of cells which cannot undergo apoptosis in the bone marrow.Keywords
This publication has 87 references indexed in Scilit:
- Regulation of B-cell growth and immunoglobulin gene transcription by interleukin-6Blood, 1992
- Recombinant interleukin (IL) 2‐induced human B cell differentiation is mediated by autocrine IL6European Journal of Immunology, 1989
- Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation.Proceedings of the National Academy of Sciences, 1989
- Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.Proceedings of the National Academy of Sciences, 1989
- Response patterns of purified myeloma cells to hematopoietic growth factorsBlood, 1989
- Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6Blood, 1989
- Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes.Published by Elsevier ,1988
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988
- The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.The Journal of Experimental Medicine, 1988
- Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).Proceedings of the National Academy of Sciences, 1985